Business Description
Palatin Technologies is a US-based drug development company focused on treatments that work through the melanocortin receptor system, a biological pathway involved in a range of medical conditions. The company is advancing several programs across obesity, sexual dysfunction, eye disease, and inflammatory bowel disease, with some candidates already in clinical trials and others in earlier stages of research. Founded in 1986 and headquartered in Monmouth Junction, New Jersey, Palatin aims to bring new classes of medicine to patients who have limited options with existing therapies.
